Redeye: BeammWave - Tune in for the tape-out
8 augusti, 15:31
8 augusti, 15:31
Redeye notes that BeammWave surprised by posting net sales of SEK1.0m, which had been anticipated in Q3 2025. Cost control remains solid, with operating expenses below expectations. Management reiterates its view that technology and market risks are diminishing. With an ongoing rights issue of up to SEK65m, the company believes its financing risk is reduced, which in turn should build confidence among its prospective customers regarding the path to volume production. While the rights issue provides financial stability, Redeye believes the next share price advance requires tangible operational catalysts. Specifically, the market will now look for the announcement of key technical achievements, such as successful tape-outs. This milestone is a critical precursor to confirming that its large, undisclosed partners are moving closer to placing volume orders.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
Attachments
8 augusti, 15:31
Redeye notes that BeammWave surprised by posting net sales of SEK1.0m, which had been anticipated in Q3 2025. Cost control remains solid, with operating expenses below expectations. Management reiterates its view that technology and market risks are diminishing. With an ongoing rights issue of up to SEK65m, the company believes its financing risk is reduced, which in turn should build confidence among its prospective customers regarding the path to volume production. While the rights issue provides financial stability, Redeye believes the next share price advance requires tangible operational catalysts. Specifically, the market will now look for the announcement of key technical achievements, such as successful tape-outs. This milestone is a critical precursor to confirming that its large, undisclosed partners are moving closer to placing volume orders.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
Attachments
Inflationen
Aktieanalyser
Rapporter
Inflationen
Aktieanalyser
Rapporter
1 DAG %
Senast
Idag, 17:14
Tjeckien köper 44 Leopard-stridsvagnar
OMX Stockholm 30
1 DAG %
Senast
2 609,15